AI in Population Health: Exploring Sub-Fields and Applications

By Sumona Bose

February 1, 2024

Introduction

Artificial intelligence (AI) has influenced various aspects of healthcare, from genetics research to clinical care. However, its adoption in population health settings has been slower. In this article, we aim to shed light on different sub-fields of AI and their potential applications in population health, emphasizing the need for decision-makers to understand AI concepts. By exploring these sub-fields, we can harness the power of AI to make more informed decisions and improve public health outcomes. This article will explore the sub fields of AI in population and public health.

Understanding AI Concepts

AI methods offer the ability to analyze vast amounts of complex and diverse data, providing valuable insights and contributing to sense making. This capacity makes AI particularly appealing for health applications, including personalized medicine. However, the term “AI” encompasses various approaches and fields, leading to confusion. To bridge this knowledge gap, we will outline different AI sub-fields and their relevance to population health.

Exploring AI Sub-Fields

Machine Learning

Machine learning, a widely used sub-field of AI, has found success in clinical problem-solving. However, its application in population health and public health has been limited. Machine learning and traditional statistical approaches have the potential to leverage big data to understand and predict healthcare and population health outcomes. However, caution must be exercised to avoid biased data and unequal access to technology, which can perpetuate health inequities.

Population Health & Responsible AI
Figure 1: Population Health and Responsible AI

Natural Language Processing (NLP)

NLP focuses on understanding and processing human language. In population health, NLP can be used to analyze large volumes of text data, such as electronic health records and social media posts, to identify patterns and trends. This can aid in disease surveillance, early detection, and monitoring of public health concerns.

Computer Vision

Computer vision involves the interpretation of visual data, such as medical images and videos. In population health, computer vision can assist in the analysis of imaging data for disease diagnosis and monitoring. It can also be used for surveillance purposes, such as monitoring social distancing compliance during pandemics.

Predictive Analytics

Predictive analytics utilizes historical data to make predictions about future events. In population health, predictive analytics can help identify individuals at risk of certain diseases or adverse health outcomes. This information can guide targeted interventions and resource allocation to prevent or mitigate health issues.

Conclusion

The field of AI holds immense potential for improving population health outcomes. While AI has already made significant advancements in genetics research and clinical care, its application in population health settings has been slower. By understanding the various sub-fields of AI and their relevance to population health, decision-makers can harness the power of AI to make more informed decisions and address public health challenges. Exploring sub fields of AI in population health makes for a necessary discourse to positively intervene in population health.

Reference url

Recent Posts

Innovations in Haematology Cell Therapy at ASH 2025

By HEOR Staff Writer

December 5, 2025

Advancing Haematology Cell Therapy Innovations at ASH 2025 AstraZeneca is significantly advancing haematology cell therapy with its largest-ever presence at the 67th American Society of Hematology (ASH) Annual Meeting and E...
Advancing EU Health Technology Assessment: Key Priorities in the HTACG Draft Annual Work Programm...

By João L. Carapinha

December 4, 2025

How will the EU Health Technology Assessment framework evolve in 2026 to improve clinical evaluations for cancer treatments and advanced therapies? The EU Health Technology Assessment (HTA) initiative coordinates standardized reviews of medicines and devices across Member States, thereby boosting...
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
What does the latest WHO guideline reveal about GLP-1 obesity therapies, as released in December 2025? This landmark document establishes the first global standards for integrating glucagon-like peptide-1 (GLP-1) receptor agonists and GIP/GLP-1 dual agonists into chronic obesity management, treat...